Upcoming Events
Past Events

American Epilepsy Society Annual Meeting

6th – 10th December 2024

Los Angeles CA, USA

Meet Dr Chris Mathes at AES 2024 where he looks forward to discussing better outcomes for people with epilepsy.

Register

Biophysical Society Annual Meeting 2025: Satellite Meeting

14th February 2025

Los Angeles, CA, USA

The Drug Discovery for Ion Channels XXV satellite meeting is hosted by Metrion, Axxam, Nanion, SB Discovery and Sophion.

Read More Register

Biophysical Society Annual Meeting 2025

15th - 19th February 2025

Los Angeles, CA, USA

Meet Dr Eddy Stevens and Dr Chris Mathes at booth 310. We also hope to see you at the satellite meeting we are co-hosting with Sophion, Axxam and Nanion on Friday 14th February.

Register

Annual Meeting of Japanese Safety Pharmacology Society 2025

20th - 21st February 2025

Osaka, Japan

Meet Dr Chris MathesDr Steve Jenkinson and Tsutomu Mori. We also hope to see you at our lunch seminar - further details to follow.

Register

Society of Toxicology Annual Meeting 2025

16th - 20th March 2025

Orlando, FL, USA

Meet Dr Chris Mathes and Dr Steve Jenkinson at booth 1244.

Register

8th RSC-BMCS / SCI Symposium on Ion Channels as Therapeutic Targets

31st March - 1st April 2025

Cambridge, UK

Meet Dr Eddy Stevens and Dr Sophie Rose at booth 1.

Register

Cambridge Ion Channel Forum

15th May 2025

Cambridge, UK

Save the date. Further details to follow.

Venue: AstraZeneca DISC, Cambridge, UK.

Sophion ICMS UK 2025

25th - 26th June 2025

Cambridge, UK

Meet Dr Sophie Rose at the Ion Channel Modulation Symposium.

Register

ELRIG Drug Discovery 2025

21st - 22nd October 2025

Liverpool, UK

Meet Dr Sophie Rose at ELRIG Drug Discovery.

Register
The Quest for New Medicines to Slow the Progression of Disability in Neurodegenerative Disorders

18th – 19th November 2024

Dr John Ridley and Dr Tony Rush look forward to this symposium will review the progress made in the quest to discover new medicines to slow the progression of disability associated with neurodegenerative disorders.

 

ELRIG Protein Sciences in Drug Discovery

18th – 19th November 2024

Dr Sophie Rose is attending this event, which will discuss high-throughput methods for protein expression, approaches for generation of antigens for antibody and vaccine discovery, analytical techniques to interrogate protein quality, and the application of cryogenic electron microscopy (cryo-EM) for druggability, as well as sequence-based predictive methods.

American College of Toxicology Annual Meeting

17th – 20th November 2024

Dr Steve Jenkinson is attending the American College of Toxicology Annual Meeting in Austin, Texas.

Webinar: Safeguarding the Heart in Drug Discovery

15th November 2024

Dr Steve Jenkinson will present ‘Assessing the cardiac safety of the Comprehensive in vitro Proarrhythmia Assay library compounds’ in this webinar delivered by Drug Discovery News, sponsored by Lumencor.

Spotlight on the Latest Rare Disease Research & Development in the UK

12th November 2024

Dr Zeki Ilkan is looking forward to discussing rare disease research over drinks and nibbles.

Newcastle University Scientific Professional Awareness Event

8th November 2024

Dr Sophie Rose is looking forward to raising awareness of scientific opportunities for life science students post-degree at Newcastle University’s Scientific Professional Awareness Event.

Axion BioSystems’ UK Maestro MEA User Meeting

29th October 2024

Tony Rush and Nicola Secomandi look forward to meeting scientists across academia and industry in the field of neuroscience, to share knowledge and foster collaborations, as well as hear about the latest advancements with the Maestro platform.

The Quest for New Medicines to Slow the Progression of Disability in Neurodegenerative Disorders

18th – 19th November 2024

John Ridley and Tony Rush look forward to this symposium will review the progress made in the quest to discover new medicines to slow the progression of disability associated with neurodegenerative disorders.

ApconiX Drug Safety Forum

17th October 2024

Meet Sophie Rose and Zeki Ilkan at the ApconiX Drug Safety Forum: A Patient First Approach to Translational Safety. From Nonclinical to Clinical.

Neuroscience 2024

6th – 9th October 2024

Chris Mathes will be attending Neuroscience 2024. Contact Chris to arrange time to meet.

Poster: #14146 Identification of venom fractions as TREK-1 modulators using Qube 384 automated patch clamp system’.

Neuroscience 2024

October 5-9

Chris Mathes will be attending ELRIG Drug Discovery ‘Connecting Minds, Transforming Science, Empowering the Community’. To secure time to meet with Chris contact us and he will be in touch.

ELRIG Drug Discovery

2-3 October 2024

Sophie Rose will be attending ELRIG Drug Discovery ‘Connecting Minds, Transforming Science, Empowering the Community’.

Safety Pharmacology Society Annual Meeting 2024

September 22nd – September 25th

Sophie Rose, Steve Jenkinson and Chris Mathes are looking forward to seeting you at SPS. You’ll find them at booth 203 in the exhibition hall, or to secure a time to meet with them contact us and they will be in touch.

Steve will present ‘Safety evaluation of the Comprehensive In Vitro Proarrythmia Library to Assess Cardiotoxicity Potential Using the VOLTA Scanner’ in Lumencor’s sponsored session on 24th September at 2:30pm – 3:00pm.

Recent Progress Towards a Potential Treatment for KCNC1-related Disorders

September 18th 2024 10am EDT | 3pm BST | 4pm CEST

Webinar:

A (Parent’s) Duty to Hope, Stephanie Telesca, Co-founder of The KCNC1 Foundation

Models and mechanisms of KCNC1-related disorders, Ethan M. Goldberg, M.D., Ph.D., Associate Professor in the Division of Neurology at The Children’s Hospital of Philadelphia

How Metrion Biosciences helped identify a potential treatment for patients with the KCNC1 variant, Scott Maidment, Head of High Throughput Screening, Metrion Biosciences

Read More
Science and Technology Solutions Exhibition

Wednesday, 11th September 2024 10:00 AM – 15:00 PM

This event is right on our doorstep as the marquee will be set-up at Granta Park, Cambridge, UK. Here you will find John Ridley and Zeki Ilkan at booth 32 so please drop by to discuss your drug discovery projects.

Linköping Ion Channel Meeting

September 11th – 12th 2024

Sophie Rose looks forward this meeting which will delve into electrophysiology with a focus on ion channels.

Sophion User Meeting – North America

August 21st – 22nd 2024

Dr Steve Jenkinson looks forward to connecting with others utilising ground breaking automated patch-clamp technology.

BioWednesday London Summer Social

July 17th 2024

Meet Zeki Ilkan, Commercial Operations Scientist, at the One Nucleus BioWednesday London Summer Social.

RICT 2024 – 58th International Conference on Medicinal Chemistry

July 3rd – July 5th 2024

Come and meet Dr Sophie Rose, Head of Business Development at the conference, who will look forward to meeting you and having topical discussions.

FENS Forum 2024

June 25th – June 29th 2024

Dr Tony Rush, Director of Neuroscience and Federico Olivero, Research Associate Scientist attended the FENS Forum which was held in Vienna, Austria for discussions on Neuroscience.

Federico presented the poster ‘Scientifica PatchScope Pro: An Integrated Calcium-Imaging and PatchClamp System Suitable for Selecting Specific Subsets of Neurons for Electrophysiological Recordings’ in poster session 06 on 28th June between 2pm – 3:30pm at Poster board PS06-28PM-442.

Sophion ICMS

June 19th – June 20th 2024

Metrion attended the conference and held discussions about the science of ion channel modulation.

Babraham Showcase

Tuesday 11th June 2024

Metrion attended the Babraham Research Campus, we welcomed you to come and meet Dr. Sophie Rose in the Cambridge Building between 9:30am and 3:30pm to find out how we could support your ion channel, cardiac safety and neuroscience drug discovery projects.

Cure CLCN4 Scientific Conference 2024

June 7th – June 8th 2024

Metrion Biosciences attended the Cure CLCN4 Scientific Conference 2024 which took place in London 7th-8th June 2024. Dr Sophie Rose, Head of Business Development met many people there.

SLAS Europe 2024 Conference

May 27th – May 29th 2024

Meet Dr Sophie Rose, Head of Business Development and Dr Scott Maidment, Head of High Throughput Screening attended the SLAS Europe 2024 conference to discuss life sciences and biotechnology.

Scott presented the poster ‘Fluorescence-based drug repurposing screen of the potassium channel, KV3.1 with V434L mutation.

In Vitro Assessment of Cardiac Risk in Drug Discovery

May 16th 2024

Joining Derek Leishman, VP of Translational and Quantitative Toxicology at Eli Lilly and Company, who shared insights on leveraging non-clinical data in regulatory integrated QTc assessment.

Steve Jenkinson, VP of Drug Discovery and Safety at Metrion Biosciences, presented a clinically translatable hIPSC cardiomyocyte model to predict QTc and QRS cardiac risk.

The webinar was chaired by Eddy Stevens, CSO, Metrion Biosciences.

Cambridge Ion Channel Forum 2024

May 8th 2024

Metrion Biosciences and AstraZeneca co-organised the Cambridge Ion Channel Forum (CICF) which took place on the 8th May 2024.

The event took place at the DISC (The Discovery Centre, AstraZeneca) at the Cambridge Biomedical Campus at the Addenbrookes Hospital site. The event comprised of a networking lunch, a series of talks, a networking coffee break and a poster session plus a drinks and pizza reception to facilitate further networking opportunities.

HESI Workshop

May 7th – May 8th 2024

Steve Jenkinson, VP Drug Discovery and Safety Assessment USA at Metrion Biosciences, will be virtually attending this event and looks forward to hearing about, and contributing to discussions on, the use of cardiac NAMs, updates from the HESI U01 subaward validation studies, FDA perspectives, and the latest work of the HESI Cardiac Safety Committee.

LifeArc Translational Sciences Summit

April 23rd 2024

Meet Dr Sophie Rose, Head of Business Development, and Dr John Ridley, Director of Commercial Operations, at the LifeArc Translational Science Summit for discussions on how translational science can bridge the gap between basic research and clinical applications

ELRIG Research and Innovation 2024

March 20th – March 21st 2024 9am - 5pm

Metrion Biosciences is attending ELRIG Research and Innovation 2024 taking place in Manchester, UK.

Metrion’s Head of Business Development, Europe Dr. Sophie Rose will be attending the meeting and if you would like to meet with her, please email info@metrionbiosciences.com.

This event will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world. The 2024 R&I meeting will focus on cutting edge innovation.

Read More
SOT 63rd Annual Meeting and ToxExpo

Start: March 10th @ 09:00 End: March 14th @ 16:30

Metrion Biosciences’ VP, Drug Discovery and Safety Assessment Dr. Steve Jenkinson will be attending the conference. To arrange a meeting with Steve at the event, please email: info@metrionbiosciences.com.

Read More
Sophion EU User Meeting 2024

March 7th – March 8th 2024 Start: March 7th @ 09:00 / End: March 8th @ 14:00

Metrion Biosciences is attending the Sophion Bioscience EU User Meeting 2024 taking place on the 7th – 8th March 2024 in Copenhagen, Denmark.

Dr Catherine Hodgson and Dr Tom Hill will be attending the meeting on behalf of Metrion.

Catherine will also be presenting at the meeting. Catherine’s presentation is entitled: ‘The dogma of Fluoride, are there alternatives to use on the Qube?’

If you would like to meet with Tom and Catherine at the event, please email info@metrionbiosciences.com.

Read More
Japanese Safety Pharmacology Society Annual Meeting

Start: February 10th @ 09:00 End: February 14th @ 17:00

Metrion Biosciences is attending the Japanese Safety Pharmacology Society Annual Meeting which is taking place on 22nd and 23rd February 2024. Metrion’s Scientists will be presenting a poster and will also have a booth at the event.

Two delegates from Metrion will be attending the meeting. If you would like to meet with them, please email info@metrionbiosciences.com.

The event will be held at Senri Life Science Center in Osaka.

Read More
Metrion Biosciences

Let’s work together

If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.
Contact us for a quote or discussion
Metrion Biosciences is a contract research organisation (CRO) specialising in high-quality preclinical drug discovery services.
magnifier
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram